Adverse event development in clinical oncology trials

[...]one minus the Kaplan-Meier estimator of the probability of the occurrence of a specific adverse event overestimates the true adverse events probability. A correct quantification of the absolute adverse events risk over time also represents an important prerequisite for a meaningful benefit-risk...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The lancet oncology 2016-07, Vol.17 (7), p.e263-e264
Hauptverfasser:	Schmoor, Claudia, Bender, Ralf, Beyersmann, Jan, Kieser, Meinhard, Schumacher, Martin
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical trials Hematology, Oncology and Palliative Medicine Prescription drugs Side effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!